FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Optimer

Sort
E.g., 2013-05-24
E.g., 2013-05-24
Enter a comma separated list of user names.

BioMimetic Therapeutics Inc. (NASDAQ:BMTI) announced it initiated enrollment in a pilot clinical trial to assess the safety and clinical utility of AugmentTM Rotator Cuff Graft for the repair of large rotator cuff tears. The randomized, controlled pilot trial is expected to include enrollment of up to 30 patients.

ADVERTISE WITH US